Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells

Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target

(2011) Masaki Shiota et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4

(2010) Fredika M. Robertson et al.   CANCER

Shear-induced Interleukin-6 Synthesis in Chondrocytes

(2010) Pu Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth

(2009) Liying Zhang et al.   AMERICAN JOURNAL OF PATHOLOGY

Prostaglandin E2 Receptors and COX Enzymes in Human Hepatocellular Carcinoma

(2009) Antonella Cusimano et al.   Annals of the New York Academy of Sciences

Programmed Cell Death Protein 4 Down-regulates Y-Box Binding Protein-1 Expression via a Direct Interaction with Twist1 to Suppress Cancer Cell Growth

(2009) M. Shiota et al.   CANCER RESEARCH

Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung

(2009) R. E. Harris   INFLAMMOPHARMACOLOGY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prostaglandin E2 Regulates Tumor Angiogenesis in Prostate Cancer

(2008) S. Jain et al.   CANCER RESEARCH

Twist Promotes Tumor Cell Growth through YB-1 Expression

(2008) M. Shiota et al.   CANCER RESEARCH

Mouse EP3 α, β, and γ Receptor Variants Reduce Tumor Cell Proliferation and Tumorigenesisin Vivo

(2008) Ines M. Macias-Perez et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Oncogenic activation of androgen receptor

(2008) Hsing-Jien Kung et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS